Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
From virtual screening to selective angiotensin II type 2 receptor ligands: discovery of a novel scaffold
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Medicinal Chemistry, Preparative Medicinal Chemistry.ORCID iD: 0000-0002-2562-1888
Stockholm Univ, Dept Organ Chem, Sci Life Lab, Drug Discovery & Dev Platform, Box 1030, SE-17121 Solna, Sweden..
Uppsala University, Science for Life Laboratory, SciLifeLab. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Medicinal Chemistry, Preparative Medicinal Chemistry.
Uppsala University, Science for Life Laboratory, SciLifeLab. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Medicinal Chemistry, Preparative Medicinal Chemistry.ORCID iD: 0000-0002-5611-1733
Show others and affiliations
2026 (English)In: Results in Chemistry, E-ISSN 2211-7156, Vol. 29, article id 103660Article in journal (Refereed) Published
Abstract [en]

The angiotensin II type 2 receptor (AT2R) is part of the renin-angiotensin aldosterone system and modulates central nervous and cardiovascular functions. During various pathological conditions the receptor is upregulated to exert vasodilating, anti-inflammatory, and neuroprotective functions, and therefore represents a promising drug-target. As part of our continuous exploration of agonist and antagonist ligands binding the AT2R, a virtual screening campaign of an in-house library of ∼82,000 compounds were performed. Several pharmacophores from known AT2R ligands were constructed, and in combination with the structural information from an AT2R homology model, we employed a ligand-based approach to identify new ligands with potential for high affinity to the receptor. Fifty hits were identified and tested in vitro, of which ten compounds, representing five scaffold clusters, were found to bind the AT2R. These clusters were validated via a hit expansion, where one of these hits, the first novel class of small molecule AT2R ligand identified in many years, was then selected for further exploration. Through structure-activity relationships studies, one ligand (compound 15a-(S,S)) with sub-micromolar AT2R affinity (Ki = 140 nM) was identified. The ligand also displayed a favorable in vitro profile; low metabolic clearance, good permeability, and fair solubility. Preliminary in vivo pharmacokinetic studies in mice revealed a good systemic exposure of the compound, with an estimated half-life of approximately six hours. The structure of compound 15a-(S,S) differs significantly from all other previously reported AT2R ligands and can serve as a prototype and starting point for further AT2R ligand optimization, and investigation into its agonistic, antagonistic or other functions.

Place, publisher, year, edition, pages
Elsevier, 2026. Vol. 29, article id 103660
Keywords [en]
RAAS, Angiotensin II type 2 receptor, Hit identification, Virtual screening, Lead generation
National Category
Medicinal Chemistry Pharmaceutical Sciences Molecular Biology
Identifiers
URN: urn:nbn:se:uu:diva-595328DOI: 10.1016/j.rechem.2026.103660ISI: 001834803400001OAI: oai:DiVA.org:uu-595328DiVA, id: diva2:2091901
Available from: 2026-08-13 Created: 2026-08-13 Last updated: 2026-08-13Bibliographically approved

Open Access in DiVA

fulltext(2414 kB)58 downloads
File information
File name FULLTEXT01.pdfFile size 2414 kBChecksum SHA-512
20277a021e2ba3f18d2c2950c359a51e5186662160d19cbfcf999626d11addf28e913160d58c738953580f724a35348a648df87aafd2688d189afeeb923154bd
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records

Patel, Jayendra Z.Wannberg, JohanSöderström, MarcusBacklund, MariaGising, JohanHallberg, MathiasIsaksson, RebeckaLarhed, Mats

Search in DiVA

By author/editor
Patel, Jayendra Z.Wannberg, JohanSöderström, MarcusBacklund, MariaGising, JohanHallberg, MathiasIsaksson, RebeckaLarhed, Mats
By organisation
Preparative Medicinal ChemistryScience for Life Laboratory, SciLifeLabDepartment of PharmacyDepartment of Pharmaceutical Biosciences
In the same journal
Results in Chemistry
Medicinal ChemistryPharmaceutical SciencesMolecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 58 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 385 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf